Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on March 13, 2018. The filing addresses corporate governance matters related to the company's 2018 Annual Meeting of Stockholders, scheduled for June 7, 2018.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meetings and does not contain financial performance data.
Material Changes
The company notes that the date of the 2018 Annual Meeting has been changed by more than 30 calendar days from the previous year's meeting. Consequently, the company is affirming the deadline for the receipt of qualified stockholder proposals under Rule 14a-8.
Guidance, Outlook, and Risks
- Shareholder Proposals: The deadline for receiving qualified stockholder proposals for inclusion in the 2018 proxy materials is April 13, 2018.
- Submission Details: Proposals must be sent to the Corporate Secretary at 5 Musick, Irvine, California 92618.
- Forward-Looking Statements: The filing includes standard disclaimers that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predictions.
- Risk Factors: Investors are directed to the "Risk Factors" section of the Annual Report on Form 10-K for the fiscal year ended December 31, 2016, for a discussion of important factors affecting the company.
Key Facts for Investor Verification
- Verify the exact time and location of the 2018 Annual Meeting in the upcoming proxy statement.
- Confirm the April 13, 2018, deadline for submitting Rule 14a-8 stockholder proposals.
- Review the Form 10-K filed on March 9, 2017, for the most recent detailed risk factors and financial data.
- Note that the registrant name in the filing is MRI Interventions, Inc., not Clearpoint Neuro, Inc.